LECAP Asset Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
Other funds holding MDT
LECAP Asset Management's MDT Position: Q3 2026 in Review
LECAP Asset Management reduced its Medtronic (MDT) stake by 47% in Q3 2026, selling an estimated $604K and leaving 7,600 shares worth $656K. The position accounts for 0.31% of the portfolio, ranked #135.
LECAP Asset Management first reported a position in MDT in Q1 2024 and has held it in 3 quarters since. The position peaked at $1.13M in Q2 2026. 1,224 funds tracked by Wall St. Rank hold MDT as of Q3 2026.
- LECAP Asset Management held 7,600 shares of Medtronic worth $656K as of Q3 2026.
- LECAP Asset Management sold 6,853 Medtronic shares in Q3 2026, an estimated $604K.
- Medtronic made up 0.31% of LECAP Asset Management's portfolio in Q3 2026, its #135 holding.
- LECAP Asset Management first reported a position in Medtronic in Q1 2024 and has held it in 3 quarters since.
- LECAP Asset Management's Medtronic position peaked at $1.13M in Q2 2026.
- 1,224 funds tracked by Wall St. Rank held Medtronic as of Q3 2026.
Based on LECAP Asset Management's 13F filing for Q3 2026, filed 27 Oct 2026.